Novonesis
380.20 DKK
+1.47 %
Less than 1K followers
NSIS B
NASDAQ Copenhagen
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
+1.47 %
+2.20 %
-6.77 %
-6.08 %
+1.33 %
-4.38 %
+8.44 %
-5.91 %
+927.57 %
Novonesis is a biochemistry company. The company develops enzymes and various microorganisms for industrial use. The enzymes are a protein used in a number of different industries, mainly in the agricultural and food industries. Novonesis products are used in various foods and clothing and the company holds sales on a global level. Novonesis was founded in 1921 and is headquartered in Bagsværd, Denmark.
Read moreMarket cap
178.05B DKK
Turnover
502.65M DKK
Revenue
31.05B
EBIT %
19.64 %
P/E
40.73
Dividend yield-%
1.12 %
Revenue and EBIT-%
Revenue B
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
20.8
2026
Interim report Q2'26
All
Research
Press releases
ShowingAll content types
Trading by management and close relations of management
HCA Morgenbørs 25/03 - Positive markeder og hele linjen
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
